Dr. Randy Nelson, Arizona State University (IMAGE)
Caption
The research team's goal is to identify more accurate HDL biomarkers -- tell-tale protein signatures -- that have the potential to be earlier and more accurate predictors of cardiovascular disease risk.
Credit
The Biodesign Institute at Arizona State University
Usage Restrictions
None
License
Licensed content